Aurobindo Pharma’s net profit rose to Rs. 712.2 crore (including Rs. 50.5 crore forex gain) in the quarter ended December 2018 as against Rs. 595 crore in the corresponding quarter a year ago on the back of a strong performance in the US, Europe and emerging markets.